Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 9:27:e930278.
doi: 10.12659/MSM.930278.

A Review of the Current Status of Clinical Management of COVID-19 in the Elderly

Affiliations
Review

A Review of the Current Status of Clinical Management of COVID-19 in the Elderly

Qiaoyun Li et al. Med Sci Monit. .

Abstract

The high infectivity and severity of SARS-CoV-2 infection (COVID-19), and our limited understanding of the biology of the novel coronavirus, as well as the lack of an effective treatment for COVID-19, have created a global pandemic. Those most likely to become seriously ill with COVID-19 are adults, especially the elderly and those who are already weak or sick. At present, a specific drug for treatment of COVID-19 has not been developed. This, combined with the typical coexistence of a variety of chronic diseases in elderly patients, makes treatment challenging at present. In addition, for elderly patients, COVID-19 isolation measures during the epidemic can easily lead to psychological problems. Thus, how to manage elderly patients has become a focus of social attention in the current circumstances. This article reviews the effects of COVID-19 and makes management suggestions for elderly patients during this epidemic period. In addition to the elderly, critically ill people are also highly susceptible to this novel coronavirus. For elderly COVID-19 patients, antiviral therapy, immune regulation, and even auxiliary respiratory therapy can be given after a comprehensive evaluation of the disease. With the approval and use of COVID-19 vaccines, it is reasonable to expect that we can conquer SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

None.

References

    1. De Virgiliis F, Di Giovanni S. Lung innervation in the eye of a cytokine storm: Neuroimmune interactions and COVID-19. Nat Rev Neurol. 2020;16(11):645–52. - PMC - PubMed
    1. Dandan L, Biao C, Yue L, Ximing X. [Clinical characteristics of cancer patients with COVID-19 and suggestions for patients management strategy during the epidemic novel coronavirus period]. Modern Oncology Medicine. 2020;28(17):3096–98. [in Chinese]
    1. Vellas C, Delobel P, de Souto Barreto P, Izopet J. COVID-19, virology and geroscience: A perspective. J Nutr Health Aging. 2020;24(7):685–91. - PMC - PubMed
    1. Yan Y, Jiajia W, Wenni W, et al. [Prevention and control management of geriatric ward in military hospital during COVID-19 period]. Military Medical Journal of Southeast China. 2020;22(4):434–35. [in Chinese]
    1. Yanming L, Hong S. [Consensus of experts in diagnosis and treatment of senile COVID-19]. Journal of Chinese Physicians. 2020;22(2):161–65. [in Chinese]

MeSH terms